Alamar Biosciences, Inc. (ALMR) stock
ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$26.48−2.20 (-7.67%)
Close on Nov 20, 2026Market cap $1.84BP/E –Yield –
Alamar Biosciences gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $20.64M | +140.6% |
| Q2 FY2026 | Jun 30, 2026 | $17.72M | +177.3% |
| Q1 FY2026 | Mar 31, 2026 | $14.46M | – |
| Q3 FY2025 | Sep 30, 2025 | $11.90M | – |
| Q2 FY2025 | Jun 30, 2025 | $8.58M | – |
| Q1 FY2025 | Mar 31, 2025 | $6.39M | – |
See a number that looks wrong?